Unfolding the recent advancements in preclinical and translational approaches treating neurodegenerative disorders.
With the advent of neural implants and novel therapies, the cure of multiple neurodegenerative disorders proves wholesome for the patients’ suffering. Increasing in the severity of neurodegenerative diseases, demands the discovery of new translational approaches in neuroscience research.
Learn from 20+ industry leading speakers who will be sharing their presentations on CNS drug discovery, Latest Optogenetic tools, kinematic techniques, Blood-Brain Barrier Proteomics and Non-Invasive electrical brain stimulation.
Case studies presented from leading technology collaborations, Interactive panel and breakout sessions along with Access to online presentations on-demand post-summit.
First ever conference on application of technology in developing neurological treatments. Meet 100+ global heads of neuroscience from the industry and Academics.
MarketsandMarkets 6th Annual Neuroscience R&D conference to be held on 5th – 6th October in London, UK aims to offer a wide space to the experts from academia and industry together to discuss novel therapeutics, emerging trends, major challenges, and interesting revolutions that could be blooming in neuroscience in near future. The conference will be centred on focusing on the most recent advancements in preclinical, translational neuroscience research while also bringing the audience's attention to the emerging role of AI and big data in neuroscience R&D space. This two-day programme will feature expert keynote presentations, cutting-edge discussions, and live case studies, giving stakeholders the chance to participate in this scientific meeting and network with industry peers while staying up to date on the most recent advancements in neuroscience research.
